Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Seitz

Showing results (151-160 of 268) with videos related to

Pageof 27
Sort By:
World Journal of Urology|June 18, 2011
Predictive factors of recurrence and survival of upper tract urothelial carcinomasGrégory Verhoest, Shahrokh F Shariat, Thomas F Chromecki, et al.
Annals of Hematology|August 13, 2015
Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivoGregor Blank, Christian Welker, Bence Sipos, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomyMehmet Özsoy, Marco Moschini, Harun Fajkovic, et al.
Urologic Oncology|September 21, 2016
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancerAurélie Mbeutcha, Shahrokh F Shariat, Malte Rieken, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2021
Primary lung carcinoma in children and adolescents - Clinical characteristics and outcome of 12 cases from the German registry for rare paediatric tumours (STEP)Sarah Voggel, Michael Abele, Christian Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2022
First-in-Humans PET/MRI of In Vivo GD2 Expression in OsteosarcomaNils Florian Trautwein, Gerald Reischl, Christian Seitz, et al.
Menopause (New York, N.Y.)|January 31, 2023
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)James A Simon, Richard A Anderson, Elizabeth Ballantyne, et al.
Urologic Oncology|January 21, 2024
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PETNicolai A Huebner, Gabriel Wasinger, Pawel Rajwa, et al.
Bone Marrow Transplantation|August 22, 2019
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activityPatrick Schlegel, Anne-Marie Lang, Marie Matela, et al.
Clinical Genitourinary Cancer|September 17, 2017
External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based StudyMalte Rieken, Luis A Kluth, Christian Seitz, et al.
Pageof 27

Showing results (151-160 of 268) with videos related to

Sort By:
Pageof 27
World Journal of Urology|June 18, 2011
Predictive factors of recurrence and survival of upper tract urothelial carcinomasGrégory Verhoest, Shahrokh F Shariat, Thomas F Chromecki, et al.
Annals of Hematology|August 13, 2015
Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivoGregor Blank, Christian Welker, Bence Sipos, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomyMehmet Özsoy, Marco Moschini, Harun Fajkovic, et al.
Urologic Oncology|September 21, 2016
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancerAurélie Mbeutcha, Shahrokh F Shariat, Malte Rieken, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2021
Primary lung carcinoma in children and adolescents - Clinical characteristics and outcome of 12 cases from the German registry for rare paediatric tumours (STEP)Sarah Voggel, Michael Abele, Christian Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2022
First-in-Humans PET/MRI of In Vivo GD2 Expression in OsteosarcomaNils Florian Trautwein, Gerald Reischl, Christian Seitz, et al.
Menopause (New York, N.Y.)|January 31, 2023
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)James A Simon, Richard A Anderson, Elizabeth Ballantyne, et al.
Urologic Oncology|January 21, 2024
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PETNicolai A Huebner, Gabriel Wasinger, Pawel Rajwa, et al.
Bone Marrow Transplantation|August 22, 2019
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activityPatrick Schlegel, Anne-Marie Lang, Marie Matela, et al.
Clinical Genitourinary Cancer|September 17, 2017
External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based StudyMalte Rieken, Luis A Kluth, Christian Seitz, et al.
Pageof 27